News
The new arrangement could cut patients' copays to $25 per month, or less, for Wegovy, Zepbound, Ozempic and Rybelsus ...
The Cigna Group (NYSE: CI)’s Evernorth division has announced a new deal with Novo Nordisk and Eli Lilly that will limit insured customers’ monthly out-of-pocket expenses for weight-loss drugs ...
Stocktwits - Cigna (NYSE: CI)’s pharmacy benefits company, Evernorth, reached pricing deals with Eli Lilly (NYSE: LLY) and Novo Nordisk (CSE: NOVOb) to reduce expenses and provide wider employer ...
Cigna has announced a deal to cap client copays on popular GLP-1 weight loss drugs by Eli Lilly and Novo Nordisk at $200 per month, a sum that would count toward a patient's deductible.
Cigna's Evernorth unit said a new coverage deal with Eli Lilly and Novo Nordisk will bring lower copays for insured patients The company hopes the new discount, which caps monthly out-of-pocket ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results